Drug Shortage Report for CUPRIMINE
| Report ID | 166020 |
| Drug Identification Number | 00016055 |
| Brand name | CUPRIMINE |
| Common or Proper name | CUPRIMINE |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLAMINE |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | N/A |
| ATC code | M01CC |
| ATC description | SPECIFIC ANTIRHEUMATIC AGENTS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2022-07-29 |
| Estimated end date | 2022-09-09 |
| Actual end date | 2022-08-31 |
| Shortage status | Resolved |
| Updated date | 2022-09-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-09-01 | French | Compare |
| v6 | 2022-09-01 | English | Compare |
| v5 | 2022-08-11 | French | Compare |
| v3 | 2022-08-11 | English | Compare |
| v4 | 2022-08-11 | English | Compare |
| v2 | 2022-08-03 | French | Compare |
| v1 | 2022-08-03 | English | Compare |
Showing 1 to 7 of 7